The mTOR pathway is also involved in the pathogenesis of tuberous sclerosis complex (TSC), which results from mutations in the TSC1 (encoding hamartin) or TSC2 (encoding tuberin) gene. Here, TSC2 is linked to tuberous sclerosis.